Publicaciones en las que colabora con Ana Maria Treviño Rodriguez–Casanova (25)

2024

  1. Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals

    AIDS reviews, Vol. 25, Núm. 4, pp. 162-172

2023

  1. Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

    Journal of Clinical Virology, Vol. 167

  2. Impact of potent nucleos(t)ide therapy on hepatitis B hospitalisations in Spain

    Alimentary Pharmacology and Therapeutics, Vol. 57, Núm. 5, pp. 540-548

  3. Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

    Journal of Clinical Virology, Vol. 167

  4. Safety considerations in the management of hepatitis C and HIV co-infection

    Expert Opinion on Drug Safety, Vol. 22, Núm. 5, pp. 363-372

  5. Treatment of hepatitis delta and HIV infection

    Liver International, Vol. 43, Núm. S1, pp. 108-115

2022

  1. Liver cancer and hepatic decompensation events in patients hospitalized with viral hepatitis in Spain

    Hepatology International, Vol. 16, Núm. 5, pp. 1161-1169

  2. Oral antivirals for the prevention and treatment of SARS-CoV-2 infection

    AIDS Reviews, Vol. 24, Núm. 1

  3. Pre-Exposure Prophylaxis for viral infections other than HIV

    Infezioni in Medicina, Vol. 30, Núm. 3, pp. 362-371

  4. Ultra-long-acting antivirals as chemical vaccines to prevent viral diseases

    Future Microbiology, Vol. 17, Núm. 11, pp. 887-897

2021

  1. Envisioning a hepatitis delta cure with new antivirals

    Future Microbiology, Vol. 16, Núm. 13, pp. 927-930

2019

  1. Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain

    Open Forum Infectious Diseases, Vol. 6, Núm. 2

  2. HTLV testing of solid organ transplant donors

    Clinical Transplantation

  3. HTLV-1 infection in solid organ transplant donors and recipients in Spain

    BMC Infectious Diseases, Vol. 19, Núm. 1

2017

  1. Drug resistance mutations in HIV-2 patients failing raltegravir and influence on dolutegravir response

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 7, pp. 2083-2088

  2. HIV type 2 epidemic in Spain: Challenges and missing opportunities

    AIDS, Vol. 31, Núm. 10, pp. 1353-1364

  3. Human T-lymphotropic virus type 1 infection and disease in Spain

    AIDS, Vol. 31, Núm. 12, pp. 1653-1663

2016

  1. Delta hepatitis: New approaches to therapy

    Future Virology, Vol. 11, Núm. 3, pp. 197-205

2015

  1. Transmitted drug resistance to rilpivirine in newly diagnosed antiretroviral naive adults

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 104.e1-104.e5

  2. Use of cohort data to estimate national prevalence of transmitted drug resistance to antiretroviral drugs in Spain (2007-2012)

    Clinical Microbiology and Infection, Vol. 21, Núm. 1, pp. 105.e1-105.e5